T2 Biosystems Receives FDA Clearance To Market T2Candida Panel For Pediatric Patients, The Only Test Detecting Sepsis-Causing Candida Species Directly From Blood In 3-5 Hours Without Blood Culture; Panel Detects Five Candida Species Responsible For...
T2 Biosystems Receives FDA Clearance To Market T2Candida Panel For Pediatric Patients, The Only Test Detecting Sepsis-Causing Candida Species Directly From Blood In 3-5 Hours Without Blood Culture; Panel Detects Five Candida Species Responsible For...
t2 biosystems獲得FDA批准，以營銷t2candida兒童患者面板，該面板是唯一可以在3-5小時內直接從血液中檢測引起敗血症的白色念珠菌物種而無需進行血液培養的測試；該面板可以檢測出五種負責是... 的白色念珠菌物種。
T2 Biosystems Receives FDA Clearance To Market T2Candida Panel For Pediatric Patients, The Only Test Detecting Sepsis-Causing Candida Species Directly From Blood In 3-5 Hours Without Blood Culture; Panel Detects Five Candida Species Responsible For 95% Of U.S. Bloodstream Infections
t2 biosystems獲得FDA批准，將T2Candida面板應用於兒科患者市場，這是唯一一種可以在3-5小時內直接從血液中檢測到引起敗血症的白色念珠菌種類的測試，無需進行血液培養；該面板可以檢測出導致美國95％血液感染的五種白色念珠菌種類。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。